Recombinant Human PTN Protein，His

PTN (Pleiotrophin) is a heparin-binding growth factor known for its diverse biological functions, including roles in neurodevelopment, angiogenesis, and tissue repair. Research into PTN began with its initial discovery as a key player in promoting neuronal differentiation and growth in the nervous system. As studies progressed, PTN was found to be involved in various disease processes, including cancer, where it may contribute to tumor growth and metastasis by enhancing angiogenic pathways. Furthermore, PTN has been implicated in the regulation of cellular interactions through its binding to specific receptors and extracellular matrix components. The exploration of PTN as a recombinant protein has gained traction due to its potential therapeutic applications, particularly in regenerative medicine and oncology. By harnessing PTN's biological properties, researchers aim to develop novel treatments that could leverage its ability to promote cell proliferation, migration, and survival in damaged tissues. Additionally, understanding the structure-function relationship of PTN at the molecular level is critical for designing effective biomolecules that can modulate its activity and enhance its therapeutic efficacy. Overall, the study of PTN and its recombinant forms is essential for uncovering new strategies in the treatment of neurodegenerative diseases, cardiovascular disorders, and various cancers.